| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |